First-of-its-Kind ProTractX3™ TTS DCB Developed to Treat Esophageal Strictures

GIE Medical developed first-of-its-kind ProTractX3™ TTS DCB designed to treat esophageal Strictures.

This device is specifically indicated for the dilation of recurrent benign esophageal strictures in adults who experience obstructive symptoms due to narrowing of the oesophagus.

The ProTractX3™ TTS DCB functions as a drug-coated balloon that can be used during gastrointestinal procedures. By utilising this innovative device, gastrointestinal physicians now have an exciting new tool to combat GI strictures. It holds the potential to provide sustained long-term patency, reducing the need for frequent treatments.

This technology is considered a promising advancement in the treatment of difficult strictures. If successfully implemented, it could lead to less complicated, less costly, and less invasive care for patients with such conditions. It may offer a more effective treatment option compared to the current standard of care.

The development of the ProTractX3™ TTS DCB holds promise in offering a potentially more effective treatment or diagnosis for life-threatening or irreversibly debilitating human diseases or conditions compared to the existing standard of care.